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Introduction
The haemogram is one of the most frequently requested laboratory tests, in hospital and
ambulatory. It is important in the evaluation of anaemia, polycythaemia, leukaemia,
infection, inflammation, among others. Therefore, given the importance of the haemogram
in the clinical context, an evaluation was performed on the results of the clinical
laboratories participating in PNAEQ’s EQA Cell Blood program.
Methods
The data used in this work is referred to the period from 2015 to 2017 and regarding each
parameter, haemoglobin, platelets, leukocytes and erythrocytes, data from 24 control
samples, distributed 4 times per year, was collected. For the calculation of the Six Sigma
metric, the inaccuracy (bias) associated to the result obtained by each laboratory for
different parameters of each sample was determined and the outlier’s treatment was
performed. In the first approach, evaluation per sample, the Normality of each sample
results was studied by applying the Kolmogorov-Smirnov test. The Box-Cox
transformation was applied whenever necessary. Regarding haemoglobin parameter, a
second approach, namely the linear regression was applied to the results of 45
laboratories(1). This model allows establishing a comparison between the laboratories’
results and the consensus value, obtained by the average of the participating laboratories.
The Sigma quality level for both approaches was obtained considering the desirable
quality specification based on the biological variation(2).
Results and discussion
After the statistical analysis of the results, the mean Sigma quality level in the sample approach was 1.71 (Figure 1), 2.22 (Figure 2),
1.57 (Figure 3) and 1.95 (Figure 4) for the parameter platelets, leukocytes, erythrocytes and haemoglobin, respectively. The mean
Sigma quality level obtained in the laboratory approach for the parameter haemoglobin was 2.64 (Figure 5). Although the Sigma quality
level ranged from 0.57 to 6.30, only 15 out of 45 laboratories had a Sigma quality level above 3 (Figure 6).
Conclusion
Continuous monitoring of the processes will be carried out, aiming to ensure that the implemented improvements continue to be practiced.
Both approaches demonstrated a need to improve the analytical process performance.
Therefore, in brainstorming meetings with the participants were identified, in the
Analyze phase, some potential causes for the low performance. The most relevant
causes consisted of the homogenization of the control sample, absence of corrective
actions resulting from the EQA reports, control acceptance criteria and calibration of
the equipment. Posteriorly, in the Improve phase, improvement actions were
elaborated and implemented. Through the pilot test, it was possible to verify
improvements in the analytical performance of the laboratories, obtaining a Sigma
quality level of 2.58, 2.27, 1.87 and 2.62, for the parameter, platelets, leukocytes,
erythrocytes and haemoglobin, respectively (Figure 7).
